YY1 is associated with inflammation and immune responses64, suggesting a potential role in modulating immune-related gene expression during IBD, and it also has been associated with the progression of NAFLD and NASH65. This evidence concerns the gene YY1 and metabolic dysfunction-associated steatotic liver disease.